DOVA PHARMACEUTICALS INC - COM (DOVA)

Q3 2019 13F Holders as of 30 Sep 2019

Type / Class
Equity / COM
Total 13F shares
9,941,760
Share change
+736,033
Total reported value
$277,871,711
Put/Call ratio
153%
Price per share
$27.95
Number of holders
67
Value change
+$32,464,344
Number of buys
38
Number of sells
36

Institutional Holders of DOVA PHARMACEUTICALS INC - COM (DOVA) as of Q3 2019

As of 30 Sep 2019, DOVA PHARMACEUTICALS INC - COM (DOVA) was held by 67 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 9,941,760 shares. The largest 10 holders included PERCEPTIVE ADVISORS LLC, ALPINE ASSOCIATES MANAGEMENT INC., BlackRock Inc., VANGUARD GROUP INC, GW&K Investment Management, LLC, RENAISSANCE TECHNOLOGIES LLC, GOLDMAN SACHS GROUP INC, Polar Asset Management Partners Inc., STATE STREET CORP, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 67 institutional shareholders reporting positions in this security for the Q3 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.